Summary
Xoft Inc (Xoft), a subsidiary of iCAD Inc, is a medical device company that develops electronic brachytherapy systems for radiation oncology applications. The company offers products such as HDR x-ray source, axxent hub, axxent controllers, vaginal applicators, surface applicators, balloon applicators, cervical applicators, physics kits, flexishield and personnel protective shields, among others. It provides rigid shield, clamp and base plate, and vacuum pumps, among others. Xoft's brachytherapy systems are used for treating early-stage breast cancer, non-melanoma skin cancer, and gynecological. The company provides support services. It has its operations in Australia, Russia, Germany, Italy, South Korea, Taiwan and others. Xoft is headquartered in San Jose, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Xoft Inc (Xoft), a subsidiary of iCAD Inc, is a medical device company that develops electronic brachytherapy systems for radiation oncology applications. The company offers products such as HDR x-ray source, axxent hub, axxent controllers, vaginal applicators, surface applicators, balloon applicators, cervical applicators, physics kits, flexishield and personnel protective shields, among others. It provides rigid shield, clamp and base plate, and vacuum pumps, among others. Xoft's brachytherapy systems are used for treating early-stage breast cancer, non-melanoma skin cancer, and gynecological. The company provides support services. It has its operations in Australia, Russia, Germany, Italy, South Korea, Taiwan and others. Xoft is headquartered in San Jose, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Xoft Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Xoft Inc Company Overview
- Xoft Inc Company Snapshot
- Xoft Inc Pipeline Products and Ongoing Clinical Trials Overview
- Xoft Inc - Pipeline Analysis Overview
- Xoft Inc - Key Facts
- Xoft Inc - Major Products and Services
- Xoft Inc Pipeline Products by Development Stage
- Xoft Inc Pipeline Products Overview
- Xoft Axxent Electronic Brachytherapy System - Colorectal Cancer
- Xoft Axxent Electronic Brachytherapy System - Colorectal Cancer Product Overview
- Xoft Axxent Electronic Brachytherapy System - Prostate Cancer
- Xoft Axxent Electronic Brachytherapy System - Prostate Cancer Product Overview
- Xoft Brain IORT System
- Xoft Brain IORT System Product Overview
- Xoft Inc - Key Competitors
- Xoft Inc - Key Employees
- Xoft Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Xoft Inc, Recent Developments
- Feb 11, 2020: First brain tumor treated with Xoft IORT in the United States
- Jan 27, 2020: iCAD Showcases Technology for Cancer “Discovery to Recovery” including ProFound AI Platform and Xoft System at Arab Health 2020 in Dubai
- Sep 16, 2019: iCAD exhibiting new updates and enhanced Xoft platform at ASTRO Including Single-Fraction IORT Solution for the Treatment of Early-Stage Breast Cancer
- Apr 15, 2019: iCAD wins three-system public bid with leading cancer organization in Spain, expanding European access to innovative cancer treatments with the Xoft System
- Jan 07, 2019: Long-term study of 1,000 tumors demonstrates effectiveness of iCAD's Xoft Electronic Brachytherapy System for early-stage breast cancer treatment
- Oct 30, 2018: Navicent Health adopts iCADs Breast Cancer Detection and Therapy Solutions to enhance patient care
- Oct 23, 2018: iCAD announces new clinical data on the Xoft Electronic Brachytherapy System for early-stage breast cancer treatment demonstrating positive results
- Oct 09, 2018: SUNY Upstate Medical University selects iCAD’s Xoft Electronic Brachytherapy System for early-stage breast cancer treatment
- Oct 03, 2018: Sanford Health Announces Adoption of iCAD''s Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment
- Oct 01, 2018: Independent, Long-Term Study Highlights Effectiveness of iCAD''s Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment
- Appendix
- Methodology
- About the Analyst
- Contact the Analyst
- Disclaimer
- Xoft Inc Pipeline Products and Ongoing Clinical Trials Overview
- Xoft Inc Pipeline Products by Equipment Type
- Xoft Inc Pipeline Products by Indication
- Xoft Inc, Key Facts
- Xoft Inc, Major Products and Services
- Xoft Inc Number of Pipeline Products by Development Stage
- Xoft Inc Pipeline Products Summary by Development Stage
- Xoft Axxent Electronic Brachytherapy System - Colorectal Cancer - Product Status
- Xoft Axxent Electronic Brachytherapy System - Colorectal Cancer - Product Description
- Xoft Axxent Electronic Brachytherapy System - Prostate Cancer - Product Status
- Xoft Axxent Electronic Brachytherapy System - Prostate Cancer - Product Description
- Xoft Brain IORT System - Product Status
- Xoft Brain IORT System - Product Description
- Xoft Inc, Key Employees
- Glossary
- Xoft Inc Pipeline Products by Equipment Type
- Xoft Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Cala Health Inc
- Best Medical International Inc
- Medical Device Group Inc
- Solar Designs, Inc.
- Medical Device Group Inc
- Solar Designs, Inc.
- Cala Health Inc
- Best Medical International Inc
